Risks and burdens of incident dyslipidaemia in long COVID: a cohort study
{{output}}
Background: Non-clinical evidence and a few human studies with short follow-ups suggest increased risk of dyslipidaemia in the post-acute phase of COVID-19 (ie, >30 days after SARS-CoV-2 infection). However, detailed large-scale ... ...
